Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00299468 · ClinicalTrials.gov registry record · Phase 1
The Effect of the Patient Activation Measure on Chronic Care
A Phase 1 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 1
- Development phase
- 283
- Enrollment target
NCT00299468: Completed Phase 1 study, sponsored by Weill Medical College of Cornell University.
NCT00299468 is a Phase 1 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 283 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (372% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00299468, a Phase 1 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 283 participants
- Enrollment target
Study Summary
We will test - in a chronically ill managed long term care population - the effectiveness of an intervention that provides nurse Care Managers with an inventory of evidence-based practices tailored to patients with different levels of knowledge, skills and confidence to engage in self-care management. Specifically, we will develop a "change package" of evidence-based hypertension (HTN) management strategies geared to patients scoring at the four different stages of activation on the Patient Activation Measure (PAM). We will randomly assign a group of interdisciplinary teams in the managed long-term care plan to intervention or control status and will train the Care Managers on the Intervention teams to use the change package in conjunction with a patient's PAM score to design - with the involvement of the patient - an individualized HTN management plan. We then will assess the impact of the intervention on patient activation and outcomes.
Interventions
- BEHAVIORAL Patient Activation Measure Intervention Package
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 283 participants |
| Start Date | 2006-04 |
| Est. Completion | 2007-03 |
| Phase | Phase 1 |
What the finished NCT00299468 record still lists
NCT00299468 is an interventional study that assigns participants to a tested intervention. The registered 283 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (372% higher).
The record links to 0 conditions, and to 1 intervention - of which Patient Activation Measure Intervention Package is the first listed.
NCT00299468 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00299468 about?
NCT00299468 is a clinical study titled "The Effect of the Patient Activation Measure on Chronic Care". We will test - in a chronically ill managed long term care population - the effectiveness of an intervention that provides nurse Care Managers with an inventory of evidence-based practices tailored to patients with different levels of knowledge, skills and confidence to engage in self-care managemen...
What is the current status of trial NCT00299468?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 283 participants. The study started on 2006-04. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00299468?
The interventions under investigation include: Patient Activation Measure Intervention Package (BEHAVIORAL).
Who is sponsoring clinical trial NCT00299468?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00299468's enrollment target sits among peer trials
283 139th of 2000 higher than 1,862 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06856694 · 283 participants · NA
RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer
- NCT05263206 · 284 participants · Phase 3
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
- NCT05769218 · 284 participants · NA
PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study
- NCT06856577 · 284 participants · Phase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia